.
ROLE OF COMPLEMENT FOR PRIMATE LENTIVIRUSES ON MUCOSAL SURFACES
The mucosal surface is a major natural route of HIV-1 entry since over 80 % of HIV transmission occurs by the mucosal route during sexual intercourse. The SIV infected rhesus macaque serves as an excellent model to study this route of infection, specially during this initial period of infection (20) (21) (22) . While it is still not completely clear how the virus is precisely transmitted across the mucosa, a number of hypothesis and concepts have been forwarded. The rectal mucosa is about 10 times thinner than the cervico-vaginal mucosa. Therefore it is relatively more vulnerable to breach during anal intercourse which allows the infected seminal fluid to directly infect dendritic cells and macrophages within the submucosal tissues (23) .
Since rectal epithelial cells do not express the CD4 glycoprotein, the main receptor of both HIV and SIV, it is assumed that non-CD4-dependent entry mechanisms must serve for viral entry into epithelial cells. Complement receptors expressed by epithelial cells may play an important role in the uptake of immune-complexed virus (21, 24) . In rectal mucosa tissues CD11b/CD18 (complement receptor type 3 (CR3)) can be detected on the surface and crypt epithelial cells, on dendritic cells and macrophages (21) . Soluble complement components as well as cell-free HIV-1 particles can also be detected in semen and cervico-vaginal secretions of HIV-1-seropositive individuals (19) . Levels of complement proteins in the semen have been shown to be 0.3 -5 % of those in blood plasma (25 and S.E. Bozas, unpublished). Both HIV and SIV are known to activate the complement system in the presence or the absence of Abs (4) which leads to deposition of C3b on the virus particle. The membrane cofactor protein CD46 is associated with the virus membrane and acts as a cofactor for cleavage of C3b to iC3b, the ligand of CR3 by factor I (reviewed in 24). Although the precise mechanism has yet to be established in vivo, it is likely that the complement system contributes to the very early events during infection with immunodeficiency viruses at the portal of entry.
INTERACTION OF OPSONISED PRIMATE LENTIVIRUSES WITH COMPLEMENT-RECEPTOR POSITIVE CELLS
Opsonised virions accumulate in retrovirusinfected hosts, which may subsequently interact with complement receptor (CR) expressing cells resulting in an enhancement of infection (2, 4, 26-30). In analogy to opsonized HIV, C3-coated SIV may interact with CR2+ B cells in the peripheral blood or in the lymphatic tissue (31-34). In case of HIV, bound viral particles are transferred to unstimulated CD4+ T cells with high efficiency (31). Other CR-positive cells indicate the follicular dendritic cells (FDC), which interact with viral antigens and intact opsonized viruses. FDC express three CRs (table 1) and represent an essential constituent of germinal centres (GC) within lymphoid follicles, where they form a threedimensional network and trap antigens on their surface. Antigens retained on FDC are complexed with immunoglobulins and complement fragments in form of immune-complex-coated bodies or "iccosomes" (35). FDC express substantial quantities of CR1 (CD35), CR2 and in addition CR3 (CD11b/CD18) (36). This unique pattern of CR expression allows FDC to interact with all generated C3 fragments bound on opsonized pathogens (Figure 1) . Recently, a main mechanism responsible for trapping HIV in GC has been elucidated. On tonsillar specimens from HIV-infected individuals, CR2 (CD21) was identified as the main binding site for HIV in GC (37) . Monoclonal antibodies (mAb) blocking the CR2-C3d interaction were shown to detach 80% of HIV-1 from lymphoid tissues of a patient during the presymptomatic stage. In contrast, detachment of HIV was not observed when mAb blocking CR1 or CR3 were used (37) . Since Fcgamma-receptors (38) and adhesion molecules like ICAM-1 and LFA-1 (39) have also been suggested to mediate attachment of virus on FDC, current experiments are under way to clarify the relative contributions of these mechanisms to HIV trapping. Complement-dependence of germinal centre formation and trapping of antigens was also shown in the murine system (40) . C3 and CR1/CR2-knock-out mice exhibit impaired germinal centre (GC) formation weak antibody responses and significantly reduced trapping. In monkeys, the role of complement for SIV-trapping in GC is still not elucidated. It is also not clear, which receptors are involved. In recent experiments cobra venom factor was administered to rhesus macaques following infection with SIVmac (41) . Although this compound can decrease the amount of systemic C3 below 5% compared to normal serum levels, no reduction in viral trapping was observed (41) . Whether this C3 reduction is sufficient to interfere with opsonization is presently unclear, since local production of low amounts of C3 seems to be sufficient to allow C3 coupling to viral antigens and restore germinal centre formation (42) . Most non-human primate studies performed with SIV use SIVmac and rhesus macaques. Experimental infection of such animals via the mucosal route or intravenous inoculation of SIVmac induces a disease pattern similar to that seen in human AIDS, although in these monkeys the disease progression is relatively more rapid than in humans. SIVmac rapidly disseminates over the majority of the lymphoid organs and induces follicular hyperplasia and infiltration of CD8+ cells within the GC (43) . Similar to the observations of HIV-1 infected humans, additional histopathological changes are observed, resulting in a progressive breakdown of the GC architecture and the development of full blown simian AIDS. The CD4 decline associated with SIV or HIV infection and the progression to AIDS is only observed in non-human primates which are infected with heterologous viral species (reviewed in 44). It is generally believed that infection of macaques with SIVmac arose from the accidental transfer of SIV from sooty mangabeys (SIVsm) (45) . In humans, HIV-1 is thought to have evolved by cross-species transmission of SIV from Chimpanzees (SIVcpz), whereas HIV-2 seems to appear most likely from infection of humans with SIVsm (46-48). In the last several years, more than 30 different SIV strains from a variety of monkey species have been identified. For most of these isolates, no evidence for induction of AIDS or AIDS-like symptoms in their natural host could be found. For example African green monkeys or sooty mangabeys maintain long term persistent infections with SIVagm and SIVsm, respectively, without developing AIDS, although these viruses replicate to high levels within these two species. Interestingly, no trapping of SIV in GC and no follicular hyperplasia or destruction of the lymphatic architecture can be observed in these animals (44, (49) (50) (51) . In addition, chimpanzees to a large extent are resistant to the development of AIDS despite an active and persistent infection. Of more than 150 chimpanzees, which have been experimentally infected with HIV today, only four have so far developed an AIDS-like disease accompanied by a loss of CD4+ T cells and trapping of HIV in the GC (52, 53) . In contrast, most animals maintained normal CD4+ T cell counts, low plasma viral loads and only transient viral deposition in the GC (53, 54) . In these non-progressors, moderate follicular hyperplasia with some infiltrating CD8+ T cells was observed occasionally, but the lymphatic architecture remained intact (55) . Thus, with the exception of the four cases of disease progression of chimpanzees experimentally injected with HIV-1 mentioned above, the remaining chimpanzees remain healthy, similar to human long-term non-progressors (53, 56) .
The lack of viral deposition in the lymph follicles may represent a key determinant for the protection against the progression to AIDS. We hypothesize that differences in the function of the complement system can provide a plausible explanation for distinct clinical outcomes of lentiviral infections. In all primates, soluble immune complexes bind to CR1 which is mainly expressed on erythrocytes. The interaction is mediated by C3b/C4b-fragments on these immune complexes, which, after binding, are transported to the liver and spleen. In these organs, immune complexes are transferred to phagocytic cells for removal (57) . A further important feature in humans, of CR1 is its decay accelerating activity for classical and alternative C3 and C5 convertases (57) . In this case, CR1 serves as a co-factor for factor Imediated cleavage and is crucial for generating iC3b, the ligand for CR3, and C3d, the main ligand for CR2 (58) . As shown for HIV, such further processed C3 fragments on immune complexes are released from erythrocytes (59) and can now interact with CRs on other cells such as CR3 on macrophages or CR2 on B cells and FDC. During this process, HIV remains infectious for permissive cells (31-34, 59, 60). In contrast to humans, chimpanzees and other non-human primates have a higher capacity of binding immune complexes (61, 62) and the alternative spliced CR1 on chimpanzees exhibit only weak co-factor activity (61, 63) . Thus most of the C3 on virus-containing immune complexes remains as C3b-fragment and is not further processed to iC3b and C3d.
OUTLOOK
Based on our preliminary findings we speculate that a discrete but highly significant shift in the processing of complement fragments or differences in complement activation by SIV may be a contributing factor which distinguishes pathogenic disease inducing as compound with non-disease inducing SIV injection of non-human primates. An equilibrium between host complement activation and virus could determine the clinical outcome after infection. Further studies are necessary to define the role of complement for lentiviral infection of different hosts which may help to envision new strategies for vaccine development against HIV.
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